Day: June 29, 2022

Consolidated Uranium Announces Results of Annual General and Special Meeting

Consolidated Uranium Announces Results of Annual General and Special Meeting

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR”, the “Company”, “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) is pleased to provide the voting results from its annual general and special meeting of shareholders held virtually today. Each of the director nominees, being Philip Williams, Anthony Milewski, Mark Raguz, John Jentz and Mark Chalmers, was re-elected as a director of the Company to serve until the next annual general meeting of shareholders, or until his successor is otherwise elected or appointed. In addition, all other matters presented for approval at the meeting were duly authorized and approved, including: Appointment of McGovern Hurley LLP, Chartered Professional Accountants as auditors of the Company; and Approval of the Company’s amended and restated Omnibus Long Term Incentive...

Continue reading

NOVAGOLD Reports Second Quarter 2022 Financial Results

NOVAGOLD Reports Second Quarter 2022 Financial Results

Donlin Gold’s Largest Drill Program in Over 10 Years Advancing in Preparation for Feasibility Work Strong Treasury of $142 Million in Cash and Term Deposits; $25 Million of Receivables in 2023 Building on the success of the 2021 drill program, drilling commenced in February 2022 with four drill rigs operating for 34,000 meters of planned drilling. As of mid-June, more than 70% of planned drilling is complete. The first set of assay results for this year’s program are expected to be published this summer. The 2022 drill program continues to yield encouraging results. In 2022, under the largest budget in over a decade, geologic modelling and interpretation work to update the resource model is underway, including engineering activities for use in an updated feasibility study that, subject to Donlin Gold LLC Board approval, is expected to...

Continue reading

FAX Capital Corp. Announces Receipt of Final Court Approval for Going Private Transaction

FAX Capital Corp. Announces Receipt of Final Court Approval for Going Private Transaction

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — FAX Capital Corp. (TSX: FXC) (the “Company”) is pleased to announce that the Ontario Superior Court of Justice (Commercial List) has issued a final order approving the previously announced plan of arrangement (the “Arrangement”) involving, among other things, the acquisition, indirectly through an acquisition company, by Fax Investments Inc. (“Fax Investments”) of all of the issued and outstanding subordinate voting shares of the Company (“Subordinate Voting Shares”) not already owned by Fax Investments or Blair Driscoll at a price of $5.18 per Subordinate Voting Share. The Arrangement was approved by shareholders at the annual general and special meeting of the Company’s shareholders held on June 24, 2022. The Arrangement is expected to be completed on or about July 4, 2022, subject to...

Continue reading

IHT DECLARES 52ND CONSECUTIVE ANNUAL DIVIDEND; FISCAL Q1 DELAYED, FILING SOON, WITH ANNUAL PROXY TO FOLLOW

IHT DECLARES 52ND CONSECUTIVE ANNUAL DIVIDEND; FISCAL Q1 DELAYED, FILING SOON, WITH ANNUAL PROXY TO FOLLOW

Phoenix, AZ, June 29, 2022 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) On June 29, 2022, the Board of Trustees of IHT announced a semi-annual dividend of $0.01 per share, payable on July 29, 2022 to shareholders of record as of July 15, 2022. This announcement continues an uninterrupted 52-year history of annual dividends. InnSuites hotel operations continue to rebound strongly, while the investment in UniGen’s diversified efficient clean energy innovation continues to progress. IHT hotel operations are maintaining their solid start in the current 2023 Fiscal Year (February 1, 2022, to January 31, 2023), First and early Second Quarter, with both the Tucson Hotel and Albuquerque Hotel achieving record results for the current Fiscal Year to date (February 1, 2022, through June 29, 2022). Revenues for the Fiscal...

Continue reading

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE 29, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg). This may include adult Omicron-adapted COVID-19 vaccines, subject to authorization from the U.S. Food and Drug Administration (FDA). The doses are planned to be delivered as soon as late summer 2022 and continue into the fourth quarter of this year. The U.S. government will pay the companies $3.2 billion upon receipt of the first 105 million doses. Under this agreement,...

Continue reading

<div>X1 Esports & Entertainment Completes IPO, Will Commence Trading on the Canadian Securities Exchange Under The Symbol “XONE”</div>

X1 Esports & Entertainment Completes IPO, Will Commence Trading on the Canadian Securities Exchange Under The Symbol “XONE”

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — X1 Esports & Entertainment (CSE: XONE) (“X1” or the “Company”), a games & media portfolio company is pleased to announce that its shares will begin trading on June 30, 2022 on the Canadian Securities Exchange (the “Exchange”). X1 will trade under the stock ticker symbol “XONE”. “We could not be more proud of our organization in reaching this milestone of listing on the Canadian Securities Exchange,” said X1 Chief Executive Officer Mark Elfenbein. “In addition to our existing assets, there is a great opportunity to acquire companies within the games and creator economy markets...

Continue reading

Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies

Field Trip Health Ltd. Receives Final Court Approval for Reorganization of the Discovery and Wellness Businesses Into Two Publicly Traded Companies

– Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.– Closing of the arrangement expected to occur in August.– Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip” or the “Corporation”), a global leader in the development and delivery of psychedelic therapies, today announces that on June 29, 2022, it received final court approval in respect of the previously announced spin-out of its clinics business to Field Trip Health & Wellness Ltd. (“Field Trip H&W”) by way of plan of arrangement (the “Arrangement”). Closing of the Arrangement remains subject to regulatory approvals, including...

Continue reading

Cytokinetics Announces Proposed Convertible Senior Notes Offering

Cytokinetics Announces Proposed Convertible Senior Notes Offering

SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market and other conditions, $450.0 million aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cytokinetics also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $90.0 million aggregate principal amount of notes. The notes will be senior, unsecured obligations of Cytokinetics and will accrue interest payable semi-annually in arrears. The notes...

Continue reading

Servus Credit Union second quarter results show $1.1 billion earnings increase

Servus Credit Union second quarter results show $1.1 billion earnings increase

EDMONTON, Alberta, June 29, 2022 (GLOBE NEWSWIRE) — Servus Credit Union Ltd. (Servus) wrapped the second quarter of the 2022 fiscal year with the following results, as compared with the corresponding period in the 2021 fiscal year: Assets increased by 3.5% to $17.9 billion Deposits increased by 4.7% to $14.8 billion Loans increased by 4.1% to $15.7 billion Retained earnings increased 8.8% to $1.1 billion Net income decreased by 15.0% to $46.8 million Provision for credit losses decreased by 82.2% Net income is down 15% due to fluctuations to credit loss recoveries. An improvement in Alberta’s economic outlook and the health of our loan book have seen our net interest income and other income rebound favourably from the setbacks caused by COVID-19. Provision for credit losses remain lower than expected, albeit higher than...

Continue reading

Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments

Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments

— Recorded Fourth Quarter and Full Fiscal Year Revenue of $31 Million and $120 Million, Respectively — — Signed $44 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $153 Million — — New Cell and Gene Therapy Analytical and Process Development Suites Now Operational and CGMP Manufacturing Suites Continue On Schedule; Myford South Facility Construction On Schedule — — Project Fiscal 2023 Revenue of $140 to $145 Million, Representing 17% – 21% Growth Over Fiscal 2022 — TUSTIN, Calif., June 29, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.